3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
11
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Ovarian Neoplasms
2
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms
1
Meningioma
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma
1
Leukemia
1
Inflammatory Breast Neoplasms
1
Hemangiosarcoma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Ependymoma
1
Endometrial Neoplasms
1
Disease Progression
1
Disease
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Lobular
1
Breast Cancer With Brain Metastasis
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
ruxolitinib
23
Cyclophosphamide
13
Whole-Body Irradiation
10
Tacrolimus
9
Mycophenolic Acid
9
fludarabine phosphate
8
fludarabine
8
Stem Cell Transplantation
8
Specimen Handling
7
Peripheral Blood Stem Cell Transplantation
7
Busulfan
5
Azacitidine
5
navitoclax
4
Sirolimus
4
Melphalan
4
Biopsy
4
luspatercept
3
fedratinib
3
Methotrexate
3
Cyclosporine
3
venetoclax
2
selinexor
2
parsaclisib
2
letermovir
2
itacitinib
2
bomedemstat
2
Injections
2
INCB057643
2
INCB039110
2
Hematopoietic Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
neratinib
×
1 year
×
Clear all
No trials found.